author_facet Woodburn, Kathryn W.
Clemens, L. Edward
Jaynes, Jesse
Joubert, Lydia-Marie
Botha, Alfred
Nazik, Hasan
Stevens, David A.
Woodburn, Kathryn W.
Clemens, L. Edward
Jaynes, Jesse
Joubert, Lydia-Marie
Botha, Alfred
Nazik, Hasan
Stevens, David A.
author Woodburn, Kathryn W.
Clemens, L. Edward
Jaynes, Jesse
Joubert, Lydia-Marie
Botha, Alfred
Nazik, Hasan
Stevens, David A.
spellingShingle Woodburn, Kathryn W.
Clemens, L. Edward
Jaynes, Jesse
Joubert, Lydia-Marie
Botha, Alfred
Nazik, Hasan
Stevens, David A.
Antimicrobial Agents and Chemotherapy
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
Infectious Diseases
Pharmacology (medical)
Pharmacology
author_sort woodburn, kathryn w.
spelling Woodburn, Kathryn W. Clemens, L. Edward Jaynes, Jesse Joubert, Lydia-Marie Botha, Alfred Nazik, Hasan Stevens, David A. 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.02690-18 <jats:p> Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to <jats:italic>Candida</jats:italic> pathogenicity and treatment ineffectiveness. Designed antimicrobial peptides (dAMPs) are chemically modified from endogenous antimicrobial peptides that provide the first line of defense against pathogens. </jats:p> Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment Antimicrobial Agents and Chemotherapy
doi_str_mv 10.1128/aac.02690-18
facet_avail Online
Free
finc_class_facet Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDI2OTAtMTg
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDI2OTAtMTg
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint American Society for Microbiology, 2019
imprint_str_mv American Society for Microbiology, 2019
issn 0066-4804
1098-6596
issn_str_mv 0066-4804
1098-6596
language English
mega_collection American Society for Microbiology (CrossRef)
match_str woodburn2019designedantimicrobialpeptidesforrecurrentvulvovaginalcandidiasistreatment
publishDateSort 2019
publisher American Society for Microbiology
recordtype ai
record_format ai
series Antimicrobial Agents and Chemotherapy
source_id 49
title Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_unstemmed Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_full Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_fullStr Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_full_unstemmed Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_short Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_sort designed antimicrobial peptides for recurrent vulvovaginal candidiasis treatment
topic Infectious Diseases
Pharmacology (medical)
Pharmacology
url http://dx.doi.org/10.1128/aac.02690-18
publishDate 2019
physical
description <jats:p> Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to <jats:italic>Candida</jats:italic> pathogenicity and treatment ineffectiveness. Designed antimicrobial peptides (dAMPs) are chemically modified from endogenous antimicrobial peptides that provide the first line of defense against pathogens. </jats:p>
container_issue 11
container_start_page 0
container_title Antimicrobial Agents and Chemotherapy
container_volume 63
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792335358815371269
geogr_code not assigned
last_indexed 2024-03-01T14:42:36.434Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Designed+Antimicrobial+Peptides+for+Recurrent+Vulvovaginal+Candidiasis+Treatment&rft.date=2019-11-01&genre=article&issn=1098-6596&volume=63&issue=11&jtitle=Antimicrobial+Agents+and+Chemotherapy&atitle=Designed+Antimicrobial+Peptides+for+Recurrent+Vulvovaginal+Candidiasis+Treatment&aulast=Stevens&aufirst=David+A.&rft_id=info%3Adoi%2F10.1128%2Faac.02690-18&rft.language%5B0%5D=eng
SOLR
_version_ 1792335358815371269
author Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A.
author_facet Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A., Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A.
author_sort woodburn, kathryn w.
container_issue 11
container_start_page 0
container_title Antimicrobial Agents and Chemotherapy
container_volume 63
description <jats:p> Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to <jats:italic>Candida</jats:italic> pathogenicity and treatment ineffectiveness. Designed antimicrobial peptides (dAMPs) are chemically modified from endogenous antimicrobial peptides that provide the first line of defense against pathogens. </jats:p>
doi_str_mv 10.1128/aac.02690-18
facet_avail Online, Free
finc_class_facet Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDI2OTAtMTg
imprint American Society for Microbiology, 2019
imprint_str_mv American Society for Microbiology, 2019
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 0066-4804, 1098-6596
issn_str_mv 0066-4804, 1098-6596
language English
last_indexed 2024-03-01T14:42:36.434Z
match_str woodburn2019designedantimicrobialpeptidesforrecurrentvulvovaginalcandidiasistreatment
mega_collection American Society for Microbiology (CrossRef)
physical
publishDate 2019
publishDateSort 2019
publisher American Society for Microbiology
record_format ai
recordtype ai
series Antimicrobial Agents and Chemotherapy
source_id 49
spelling Woodburn, Kathryn W. Clemens, L. Edward Jaynes, Jesse Joubert, Lydia-Marie Botha, Alfred Nazik, Hasan Stevens, David A. 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.02690-18 <jats:p> Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to <jats:italic>Candida</jats:italic> pathogenicity and treatment ineffectiveness. Designed antimicrobial peptides (dAMPs) are chemically modified from endogenous antimicrobial peptides that provide the first line of defense against pathogens. </jats:p> Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment Antimicrobial Agents and Chemotherapy
spellingShingle Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A., Antimicrobial Agents and Chemotherapy, Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment, Infectious Diseases, Pharmacology (medical), Pharmacology
title Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_full Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_fullStr Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_full_unstemmed Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_short Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
title_sort designed antimicrobial peptides for recurrent vulvovaginal candidiasis treatment
title_unstemmed Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
topic Infectious Diseases, Pharmacology (medical), Pharmacology
url http://dx.doi.org/10.1128/aac.02690-18